Non-invasive screening method for simultaneous evaluation of in vivo growth factor release profiles from multiple ectopic bone tissue engineering implants
- 25 August 2008
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 130 (1), 15-21
- https://doi.org/10.1016/j.jconrel.2008.05.004
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineeringBiomaterials, 2008
- Validation of a method for non-invasive in vivo measurement of growth factor release from a local delivery system in boneJournal of Controlled Release, 2006
- Bone-Tissue-Engineering Material Poly(propylene fumarate): Correlation between Molecular Weight, Chain Dimensions, and Physical PropertiesBiomacromolecules, 2006
- Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate)Journal of Biomedical Materials Research Part A, 2006
- Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphateBiomaterials, 2005
- Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2Biomaterials, 2004
- rhBMP‐2 injected in a calcium phosphate paste (α‐BSM) accelerates healing in the rabbit ulnar osteotomy modelJournal of Orthopaedic Research, 2003
- Controlled Release from Poly(Lactic-Co-Glycolic Acid) Microspheres Embedded in an Injectable, Biodegradable Scaffold for Bone Tissue EngineeringMaterials Science Forum, 2003
- Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinductionin vivoJournal of Biomedical Materials Research, 1999
- Interaction of Recombinant Human Bone Morphogenetic Protein-2 with Poly (d,lLactide-co-glycolide) MicrospheresPharmaceutical Development and Technology, 1996